Every material Form 8-K Lifeward Ltd. has filed with the SEC since October 01, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Lifeward Ltd. said its Board appointed Ronen Tsimerman as chief financial officer, principal financial officer and principal accounting officer, effective November 1, 2026. The filing describes his prior CFO roles at IceCure Medical, Insuline Medical and Mer-Group, and his pay terms are tied to shareholder approval of a renewed compensation policy at the October 30, 2026 annual meeting.
Appointed by the Board on October 26, 2026; effective November 1, 2026
Gross monthly base salary of NIS 70,000, plus an annual performance-based bonus with a target of not less than four monthly salaries
Three-month termination notice, rising to four months for either party after a change in the CEO
Lifeward Ltd. said on October 4, 2026 that Rami Aviram, whom it had appointed as Chief Financial Officer effective November 1, 2026, has decided not to join and will not take the role. Josh Hexter will continue as interim principal financial officer and principal accounting officer until a successor is appointed, and the company is searching for a permanent CFO. The change leaves the finance leadership role unfilled and without a set date for a successor.
Rami Aviram informed the company on October 4, 2026 that he will not join as CFO, which was originally set for November 1, 2026.
Josh Hexter remains interim principal financial officer and principal accounting officer, with no additional compensation for these duties.
The company is conducting a search for a permanent CFO and will announce a successor when the search concludes.
Lifeward's Chief Financial Officer, principal financial officer and principal accounting officer, Almog Adar, left the role effective September 30, 2026. Interim CEO Josh Hexter has been designated to also serve as interim principal financial officer and principal accounting officer from October 1, 2026, until Rami Aviram takes over as CFO on November 1, 2026, as previously disclosed.
Almog Adar's departure as CFO became effective September 30, 2026.
Josh Hexter, Interim CEO, also serves as interim principal financial officer and principal accounting officer effective October 1, 2026.
Rami Aviram's appointment as CFO becomes effective November 1, 2026, as previously disclosed in the August 31, 2026 Form 8-K.
Hexter will receive no additional compensation for the interim finance role.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Lifeward Ltd. filing is on SEC EDGAR ↗. 8-K briefs of other companies →